From India's anti-hangover brand Morning Fresh's new product development plans to H&H Group adopting the 'rotating CEO' model, and new research findings on COVID-19 and nutritional interventions, here are the most-read stories on NutraIngredients-Asia in December 2023.
India-based Morning Fresh is actively expanding its portfolio across categories and formats to fulfil rising demand for functional products, particularly ready-to-drink (RTD) beverages.
Swisse and Biostime’s parent firm Health and Happiness Group (H&H Group) is adopting a ‘rotating CEO’ model after its most recent leader stepped down following a 2.5-month stint to pursue ‘other personal and professional interests’.
More rigorous and well-designed investigations are needed to explore the initial promise of complementary medicine and supplementation in aiding attempts to tackle long COVID.
Infants who were fed on a novel milk formula containing large milk phospholipids coated droplets in the first four months of life were found to have a body mass index (BMI) and blood pressure that were similar to breastfed infants, according to a five-year follow-up study by Danone.
New Zealand’s natural health products and functional foods sectors are brimming with science and research, however, yet another recent regulatory blow has again left the industry deeply frustrated.
Nestle has launched in China its first growing up formula containing human milk oligosaccharides (HMOs), namely 2'-fucosyllactose (2'FL) and lacto-N-(neo)tetraose (LNnT).
Kirin Holdings and Kao Corporation have collaborated to introduce a dual-function supplement targeting immunity and visceral fat, said to be two increasingly top-of-mind concerns faced by the Japanese population.
South Korea’s Ministry of Food and Drug Safety (MFDS) says that vitamin K2 could be approved as a health functional food ingredient by March 2024.
The supplementation of a product containing iron and five other vitamins and minerals has shown to significantly increase haemoglobin levels in women suffering from mild to moderate iron deficiency anaemia, according to a trial conducted by Procter and Gamble (P&G).
Mumbai-based capsule manufacturing giant ACG says there is a “big space” in the personalised nutrition sector for the development of supplements that come in novel capsule designs, allowing not only a greater variety, but also new formulation opportunities.
